Type
Closure
Country
Denmark
Region
Vestsjællands amt;
Location of affected unit(s)
Kalundborg
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

100 jobs
Number of planned job losses
Job loss
Announcement Date
9 November 2009
Employment effect (start)
1 January 2010
Foreseen end date
30 April 2010

Description

On 9 November 2009, Denmark-based manufacturer of insulin Novo Nordisk announced the closure of the factory in Kalundborg where 100 jobs will be cut. Further 230 employees will be relocated to other factories. The factory in Kalundbord has 2,100 employees and Novo employs 5,600 people in Denmark.


Sources

  • 10 November 2009: politiken.dk

Citation

Eurofound (2009), Novo Nordisk, Closure in Denmark, factsheet number 69918, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69918.